I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 11 studies | 23% ± 6% | |
| B cell | 10 studies | 20% ± 5% | |
| fibroblast | 9 studies | 21% ± 6% | |
| plasma cell | 7 studies | 26% ± 9% | |
| naive B cell | 7 studies | 22% ± 4% | |
| macrophage | 6 studies | 20% ± 4% | |
| epithelial cell | 5 studies | 35% ± 14% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 20% ± 2% | |
| natural killer cell | 4 studies | 19% ± 4% | |
| memory B cell | 4 studies | 19% ± 3% | |
| pericyte | 4 studies | 19% ± 3% | |
| astrocyte | 4 studies | 21% ± 2% | |
| basal cell | 4 studies | 23% ± 9% | |
| goblet cell | 4 studies | 35% ± 17% | |
| plasmacytoid dendritic cell | 4 studies | 22% ± 8% | |
| classical monocyte | 3 studies | 26% ± 5% | |
| conventional dendritic cell | 3 studies | 26% ± 9% | |
| hematopoietic precursor cell | 3 studies | 19% ± 5% | |
| non-classical monocyte | 3 studies | 25% ± 3% | |
| GABAergic neuron | 3 studies | 28% ± 7% | |
| glutamatergic neuron | 3 studies | 36% ± 9% | |
| abnormal cell | 3 studies | 18% ± 4% |
